CORONA Remedies Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 8(2)'.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CORONA Remedies Limited has submitted a disclosure to the stock exchange as required under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. This regulation requires designated persons and their immediate relatives to disclose trades in the company's shares when the aggregate value crosses specified thresholds (typically over Rs. 10 lakh in a quarter). The filing signals compliance with insider trading disclosure norms. No specific transaction details or value figures are mentioned in the headline, and the full content of the intimation has not been shared.
This is a routine regulatory compliance filing and generally has no material impact on stock price. It indicates that insiders or their relatives may have traded in the shares, but the actual transaction details would need to be reviewed to assess any meaningful impact.